{"paper_id": "6532fa80e43ff0ecc469bbfa45a05731128262e4", "metadata": {"title": "Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity", "authors": [{"first": "Julia", "middle": [], "last": "Niessl", "suffix": "", "affiliation": {"laboratory": "", "institution": "Research Centre of the Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)", "location": {"settlement": "Montreal", "region": "QC", "country": "Canada"}}, "email": ""}, {"first": "Amy", "middle": ["E"], "last": "Baxter", "suffix": "", "affiliation": {"laboratory": "", "institution": "Research Centre of the Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)", "location": {"settlement": "Montreal", "region": "QC", "country": "Canada"}}, "email": ""}, {"first": "Pilar", "middle": [], "last": "Mendoza", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Mila", "middle": [], "last": "Jankovic", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Yehuda", "middle": ["Z"], "last": "Cohen", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Allison", "middle": ["L"], "last": "Butler", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Ching-Lan", "middle": [], "last": "Lu", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Mathieu", "middle": [], "last": "Dub\u00e9", "suffix": "", "affiliation": {"laboratory": "", "institution": "Research Centre of the Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)", "location": {"settlement": "Montreal", "region": "QC", "country": "Canada"}}, "email": ""}, {"first": "Irina", "middle": [], "last": "Shimeliovich", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Henning", "middle": [], "last": "Gruell", "suffix": "", "affiliation": {"laboratory": "Laboratory of Experimental Immunology", "institution": "University of Cologne", "location": {"settlement": "Cologne", "country": "Germany"}}, "email": ""}, {"first": "Florian", "middle": [], "last": "Klein", "suffix": "", "affiliation": {"laboratory": "Laboratory of Experimental Immunology", "institution": "University of Cologne", "location": {"settlement": "Cologne", "country": "Germany"}}, "email": ""}, {"first": "Marina", "middle": [], "last": "Caskey", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Michel", "middle": ["C"], "last": "Nussenzweig", "suffix": "", "affiliation": {"laboratory": "Laboratory of Molecular Immunology", "institution": "The Rockefeller University", "location": {"settlement": "New York", "region": "NY", "country": "USA"}}, "email": ""}, {"first": "Daniel", "middle": ["E"], "last": "Kaufmann", "suffix": "", "affiliation": {"laboratory": "", "institution": "Research Centre of the Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)", "location": {"settlement": "Montreal", "region": "QC", "country": "Canada"}}, "email": "daniel.kaufmann@umontreal.ca"}]}, "abstract": [], "body_text": [{"text": "PBMCs were stimulated with HIV-1 Gag peptide pools for 6h and cytokine production was evaluated by ICS. (a) Gating strategy for identification of CD8 + and CD4 + T cells. For CD8 + T cells, CD8 + CD3 -CD56 + NK cells were excluded from analysis. CD3 -CD56cells were included due to CD3 downregulation on T cells after stimulation. (bc) Representative plots showing respective cytokine staining in DMSO control or Gagstimulated CD8 + (b) or CD4 + T cells (c). Flow panels in (a-c) are representative of n=24 biologically independent individuals analyzed (n=9 bNAb+ATI individuals with prolonged viral suppression, n=2 bNAb+ATI individuals with early rebound, and n=13 individuals on continuous ART). ", "cite_spans": [], "ref_spans": [], "section": "Supplementary Figure 1: Gating strategy for intracellular detection of cytokines in T cells after Gag peptide stimulation"}, {"text": "a 5 SSC-A FSC-H SSC-H FSC-A FSC-W SSC-W", "cite_spans": [], "ref_spans": [], "section": "Supplementary Figure 2"}, {"text": "SSC-A CD8-APC-Fire750 CD3-BV605 Aquavivid/CD14-/CD19-V500 CD4-BUV496 CD56-BUV737", "cite_spans": [], "ref_spans": [], "section": "Lymphocytes Single cells Single cells"}], "bib_entries": {"BIBREF1": {"ref_id": "b1", "title": "RAEQASQEVKNWMTE Gag", "authors": [{"first": "", "middle": [], "last": "Gag", "suffix": ""}], "year": null, "venue": "", "volume": "77", "issn": "", "pages": "305--319", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "45 EGATPQDLNTMLNTV Gag(177-191) 61 STLQEQIGWMTNNPP Gag(241-255) 80 MTETLLVQNANPDCK Gag", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "317--331", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "99 FNCGKEGHIAKNCRA Gag(393-407) 100 KEGHIAKNCRAPRKK Gag", "authors": [{"first": "", "middle": [], "last": "Raeqasqevknwmte Gag", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "397--411", "other_ids": {}}}, "ref_entries": {"FIGREF2": {"text": "Gating strategy for identification of HIV-1-specific T cell responses by AIM assayPBMCs were stimulated with HIV-1 peptide pools for 18h and surface expression of AIM molecules were analyzed on CD8 + and CD4 + T cells. DMSO-treated PBMCs served as negative control. (a) Gating strategy for identification of CD8 + and CD4 + T cells. For CD8 + T cells, CD8 + CD3 -CD56 + NK cells were excluded from analysis. CD3 -CD56cells were included due to CD3 downregulation on T cells after stimulation. (b) Representative plot showing co-expression of PD-L1/CD69, 4-1BB/CD69 and PD-L1/4-1BB for CD8 + (upper graphs) and CD4 + T cells (lower graphs) after DMSO treatment or HIV-1 Gag stimulation. Flow panels in (a-b) are representative of n=9 biologically independent bNAb+ATI individuals.", "latex": null, "type": "figure"}, "TABREF2": {"text": "*One test: 2M PBMCs in 100\u00b5l staining buffer for surface and intracellular detection or 2M PBMCs in 500\u00b5l of media for staining during culture.Supplementary Table 2. Flow cytometry antibody staining panel for PD-L1/CD69/4-1BB AIM assay*One test: 5M PBMCs in 100\u00b5l staining buffer.", "latex": null, "type": "table"}, "TABREF3": {"text": "Table 1. Flow cytometry antibody staining panel for intracellular cytokine detection", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>Volume per test (\u00b5l)* </td></tr><tr><td>Target </td><td>Fluorochrome </td><td>Clone </td><td>Supplier </td><td>Detection</td><td>Catalog number </td><td>Lot number </td><td>\u00a0</td></tr><tr><td>CD3 </td><td>BUV395 </td><td>UCHT1 </td><td>BD Biosciences </td><td>Surface </td><td>563548 </td><td>6343984 </td><td>3 </td></tr><tr><td>CD4 </td><td>BUV496 </td><td>SK3 </td><td>BD Biosciences </td><td>Surface </td><td>564651 </td><td>9080989 </td><td>4 </td></tr><tr><td>CD8 </td><td>APC-Fire750 </td><td>SK1 </td><td>Biolegend </td><td>Surface </td><td>344745 </td><td>B237278 </td><td>0.5 </td></tr><tr><td>CD14 </td><td>BV510 </td><td>M5E2 </td><td>Biolegend </td><td>Surface </td><td>301842 </td><td>B250901 </td><td>3 </td></tr><tr><td>CD19 </td><td>BV510 </td><td>H1B19 </td><td>Biolegend </td><td>Surface </td><td>302242 </td><td>B239285 </td><td>3 </td></tr><tr><td>CD40L </td><td>BV421 </td><td>TRAP1 </td><td>BD Biosciences </td><td>Intracellular </td><td>563886 </td><td>6280762 </td><td>5 </td></tr><tr><td>CD56 </td><td>BUV737 </td><td>NCM16.2 </td><td>BD Biosciences eBioscience </td><td>Surface </td><td>564448 </td><td>8288818 </td><td>2.5 </td></tr><tr><td>CD69 </td><td>PerCP-eFluor710 </td><td>FN50 </td><td>\u00a0</td><td>Intracellular </td><td>46-\n0699-42 </td><td>1920361 </td><td>4 </td></tr><tr><td>CD107A </td><td>BV786 </td><td>H4A3 </td><td>BD Biosciences </td><td>Staining during culture </td><td>563869 </td><td>8144866 </td><td>5 </td></tr><tr><td>IFN\u03b3 </td><td>PE-Cy7 </td><td>B27 </td><td>BD Biosciences </td><td>Intracellular </td><td>557643 </td><td>7202642 </td><td>4 </td></tr><tr><td>IL-2 </td><td>PE-Dazzle594 </td><td>MQ1-17H12 </td><td>Biolegend </td><td>Intracellular </td><td>500344 </td><td>B245312 </td><td>3.5 </td></tr><tr><td>MIP-1\u03b2 </td><td>PE </td><td>D21-1351 </td><td>BD Biosciences </td><td>Intracellular </td><td>550078 </td><td>8176503 </td><td>1 </td></tr><tr><td>TNF\u03b1 </td><td>APC </td><td>MAb11 </td><td>BD Biosciences </td><td>Intracellular </td><td>562084 </td><td>7163931 </td><td>1.5 </td></tr></table></body></html>"}, "TABREF4": {"text": "Table 2. Flow cytometry antibody staining panel for PD-L1/CD69/4-1BB AIM assay", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>Volume per test (ul)* </td></tr><tr><td>Target </td><td>Fluorochrome </td><td>Clone </td><td>Supplier eBioscience </td><td>Catalog number </td><td>Lot number </td><td>\u00a0</td></tr><tr><td>CD3 </td><td>PerCP-eFluor710 </td><td>SK7 </td><td>\u00a0</td><td>46-0036 </td><td>1941534 </td><td>3 </td></tr><tr><td>CD4 </td><td>BUV496 </td><td>SK3 </td><td>BD Biosciences </td><td>564651 </td><td>9080989 </td><td>4 </td></tr><tr><td>CD8 </td><td>BV711 </td><td>RPA-T8 </td><td>Biolegend </td><td>301044 </td><td>B237121 </td><td>2 </td></tr><tr><td>CD14 </td><td>BV510 </td><td>M5E2 </td><td>Biolegend </td><td>301842 </td><td>B250901 </td><td>3 </td></tr><tr><td>CD19 </td><td>BV510 </td><td>H1B19 </td><td>Biolegend </td><td>302242 </td><td>B239285 </td><td>3 </td></tr><tr><td>CD38 </td><td>PE </td><td>HB7 </td><td>BD Biosicences </td><td>342371 </td><td>8234511 </td><td>10 </td></tr><tr><td>CD56 </td><td>BUV737 </td><td>NCM16.2 </td><td>BD Biosciences </td><td>564448 </td><td>8288818 </td><td>2.5 </td></tr><tr><td>CD69 </td><td>BUV395 </td><td>FN50 </td><td>BD Biosciences </td><td>564364 </td><td>8242749 </td><td>5 </td></tr><tr><td>CD137 (4-1BB) </td><td>PE-Cy7 </td><td>4B4-1 </td><td>Biolegend </td><td>309818 </td><td>B258325 </td><td>5 </td></tr><tr><td>HLA-DR </td><td>APC-eFluor780 </td><td>LN3 </td><td>eBioscience </td><td>47-9956 </td><td>4312829 </td><td>2.5 </td></tr><tr><td>PD-1 </td><td>Alexa Fluor 647 </td><td>EH12.2H\n7 </td><td>Biolegend </td><td>329910 </td><td>B241533 </td><td>2.5 </td></tr><tr><td>PD-L1 </td><td>BV421 </td><td>29E2A3 </td><td>Biolegend </td><td>329714 </td><td>B258010 </td><td>5 </td></tr></table></body></html>"}, "TABREF5": {"text": "Table 4. HIV Gag sequence targeted at week 12", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>HIV Gag epitope </td><td>targeted at week 12 </td></tr><tr><td>ID </td><td>Peptide </td><td>Sequence </td><td>Position in Consensus B sequence </td></tr><tr><td># </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>61 </td><td>STLQEQIGWMTNNPP </td><td>Gag(241-255) </td></tr><tr><td>\u00a0</td><td>74 </td><td>FRDYVDRFYKTLRAE </td><td>Gag(293-307) </td></tr><tr><td>9241 </td><td>75 </td><td>VDRFYKTLRAEQASQ </td><td>Gag(297-311) </td></tr><tr><td>\u00a0</td><td>79 </td><td>VKNWMTETLLVQNAN </td><td>Gag(313-327) </td></tr><tr><td>\u00a0</td><td>5 </td><td>EKIRLRPGGKKKYKL </td><td>Gag(17-31) </td></tr><tr><td>9244 </td><td>77 </td><td>RAEQASQEVKNWMTE </td><td>Gag(305-319) </td></tr><tr><td>\u00a0</td><td>45 </td><td>EGATPQDLNTMLNTV </td><td>Gag(177-191) </td></tr><tr><td>9246 </td><td>61 </td><td>STLQEQIGWMTNNPP </td><td>Gag(241-255) </td></tr><tr><td>\u00a0</td><td>80 </td><td>MTETLLVQNANPDCK </td><td>Gag(317-331) </td></tr><tr><td>\u00a0</td><td>77 </td><td>RAEQASQEVKNWMTE </td><td>Gag(305-319) </td></tr><tr><td>9247 </td><td>99 </td><td>FNCGKEGHIAKNCRA </td><td>Gag(393-407) </td></tr><tr><td>\u00a0</td><td>100 </td><td>KEGHIAKNCRAPRKK </td><td>Gag(397-411) </td></tr><tr><td>\u00a0</td><td>11 </td><td>LERFAVNPGLLETSE </td><td>Gag(41-55) </td></tr><tr><td>\u00a0</td><td>16 </td><td>LGQLQPSLQTGSEEL </td><td>Gag(61-75) </td></tr><tr><td>\u00a0</td><td>20 </td><td>SLYNTVATLYCVHQR </td><td>Gag(77-91) </td></tr><tr><td>\u00a0</td><td>40 </td><td>KVVEEKAFSPEVIPM </td><td>Gag(157-171) </td></tr><tr><td>9252 </td><td>45 </td><td>EGATPQDLNTMLNTV </td><td>Gag(177-191) </td></tr><tr><td>\u00a0</td><td>67 </td><td>WIILGLNKIVRMYSP </td><td>Gag(265-279) </td></tr><tr><td>\u00a0</td><td>75 </td><td>VDRFYKTLRAEQASQ </td><td>Gag(297-311) </td></tr><tr><td>\u00a0</td><td>76 </td><td>YKTLRAEQASQEVKN </td><td>Gag(301-315) </td></tr><tr><td>\u00a0</td><td>92 </td><td>EAMSQVTNSATIMMQ </td><td>Gag(365-379) </td></tr><tr><td>9255 </td><td>5 </td><td>EKIRLRPGGKKKYKL </td><td>Gag(17-31) </td></tr></table></body></html>"}, "TABREF6": {"text": "Table 5. Flow cytometry antibody staining panel for HIV-1 suppression assay", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>Volume per test (\u00b5l)* </td></tr><tr><td>Target </td><td>Fluorochrome </td><td>Clone </td><td>Supplier eBioscience </td><td>Detection</td><td>Catalog number </td><td>Lot number </td><td>\u00a0</td></tr><tr><td>CD3 </td><td>PerCP-eFluor710 </td><td>SK7 </td><td>\u00a0</td><td>Surface </td><td>460036 </td><td>1941534 </td><td>3 </td></tr><tr><td>CD4 </td><td>PE-Cy7 </td><td>RPA-T4 </td><td>BD Biosciences </td><td>Surface </td><td>560649 </td><td>9086795 </td><td>4 </td></tr><tr><td>CD8 </td><td>BV711 </td><td>RPA-T8 </td><td>Biolegend </td><td>Surface </td><td>301044 </td><td>B237121 </td><td>2 </td></tr><tr><td>CD14 </td><td>BUV737 </td><td>M5E2 </td><td>BD Biosciences </td><td>Surface </td><td>564444 </td><td>7150893 </td><td>3 </td></tr><tr><td>CD19 </td><td>BUV737 </td><td>SJ25C1 </td><td>BD Biosciences </td><td>Surface </td><td>564303 </td><td>5100759 </td><td>3 </td></tr><tr><td>HIV-1 Gag </td><td>RD-1/PE </td><td>KC57</td><td>Beckman Coulter </td><td>Intracellular </td><td>6604667 </td><td>7433072 </td><td>1 </td></tr></table></body></html>"}}, "back_matter": []}